Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

By Mitchell Cathrine   Gregersen Nerine   Krause Amanda  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 953-963

Future Medicine

Access to resources Recommend Favorite

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

By Wu Alan HB   Wang Ping   Smith Andrew   Haller Christine   Drake Katherine   Linder Mark   Valdes Roland  

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 169-178

Future Medicine

Access to resources Recommend Favorite

Variant VKORC1 and CYP2C9 Alleles in Patients with Diffuse Alveolar Hemorrhage Caused by Oral Anticoagulants

By Wijnen Petal A.   Linssen Catharina F.   Haenen Guido R.   Bekers Otto   Drent Marjolein  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 23-30

Adis International

Access to resources Recommend Favorite

Platform evaluation for rapid genotyping of CYP2C9 and VKORC1 alleles

By Joshi Victoria A   Duffy Elizabeth   Funke Birgit H   Farwell Lisa M   Mancini-Dinardo Debora   Kucherlapati Raju  

Personalized Medicine, Vol. 6, Iss. 4, 2009-07 ,pp. : 449-457

Future Medicine

Access to resources Recommend Favorite

High carrier prevalence of combinatorial CYP2C9 and VKORC1 genotypes affecting warfarin dosing

By Ruañño Gualberto   Thompson Paul D   Villagra David   Bower Bruce   Kocherla Mohan   Yazdanpanah Golriz   Seip Richard L   Windemuth Andreas   White C Michael   Duconge Jorge   Holford Theodore R   Wu Alan HB  

Personalized Medicine, Vol. 5, Iss. 3, 2008-05 ,pp. : 225-232

Future Medicine

Access to resources Recommend Favorite